Plasma therapy on COVID-19 patients has not been found effective in reducing the progression to severe disease or death and is dropped from the clinical management guidelines, the Indian Council of Medical Research (ICMR) stated late Monday night. An Indian Council of Medical Research (ICMR) official said the task force "revised" the Clinical Guidance for Management of Adult COVID-19 Patients and "dropped convalescent plasma (off label)". With the cases surging in the country, there has been a spur in the demand for plasma donors, even as experts raise concerns over the efficacy of plasma therapy for Covid-19 patients. In the plasma therapy, antibodies from the blood of a patient who has recovered from COVID-19 are used to treat serious patients. "Current research evidence unanimously indicates that there is no benefit offered by convalescent plasma for treatment of COVID-19.

Source: Mint May 17, 2021 17:27 UTC